Zhang et al. studied the abnormal expression of ADAM9 in human resected non-small cell lung cancer and found that, compared with normal lung tissues, ADAM9 was highly expressed in lung tumors, and ADAM9 overexpression was an independent factor for shortened survival time [9, 10]. Here, ADAM9 is linked to non-small cell lung carcinoma.